(19)
(11) EP 4 099 983 A1

(12)

(43) Date of publication:
14.12.2022 Bulletin 2022/50

(21) Application number: 21710048.6

(22) Date of filing: 08.02.2021
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 9/14(2006.01)
A61M 15/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0075; A61K 9/145; A61M 2202/064; A61P 11/00; A61K 31/352; A61M 2209/06; A61M 15/0028; A61M 15/002; A61M 15/0061; A61M 15/0031; A61M 15/0021; A61K 31/05; A61K 36/185
 
C-Sets:
A61M 2202/064, A61M 2202/0007;
(86) International application number:
PCT/IB2021/051000
(87) International publication number:
WO 2021/156839 (12.08.2021 Gazette 2021/32)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 06.02.2020 IT 202000002368

(71) Applicant: SOFAR S.p.A.
20060 Trezzano Rosa (MI) (IT)

(72) Inventors:
  • BIFFI, Andrea
    20060 Trezzano Rosa [MI] (IT)
  • FIORE, Walter
    20060 Trezzano Rosa [MI] (IT)

(74) Representative: Benedetto, Marco 
Marben S.r.l. Via Larga, 16
20122 Milano
20122 Milano (IT)

   


(54) COMPOSITION IN THE FORM OF POWDER CONTAINING AN EXTRACT OF CANNABIS SATIVA FOR THE TREATMENT OF INFLAMMATIONS OR INFECTIONS OR ALLERGIES OF THE RESPIRATORY SYSTEM AND /OR HYPERSECRETION OF THE MUCUS, AND DEVICE FOR ITS DOSAGE